Stanford Cancer Institute
Stanford Cancer Institute
批准号:
10831721
负责人:
STEVEN E ARTANDI
金额:
$12.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
未结题
起止时间:
2007-06-04 至 2027-05-31
关键词:
AddressBasic ScienceBiomedical EngineeringBiometryCancer BurdenCancer EtiologyCancer PatientCatchment AreaClinical ResearchCommunitiesComplexCountyDevelopmentDiagnosisEffectivenessEquityFinancial SupportFosteringFoundationsHealth Services AccessibilityHealth systemHospitalsIncentivesIncidenceMalignant NeoplasmsMedicalMissionOutcomePatientsPoliciesPopulation HeterogeneityPopulation SciencesResearchResourcesSystemTranslationsUniversitiesaccess disparitiesanticancer researchcancer carecancer health disparitycancer preventioncancer survivalcare burdencare deliverycare systemscharity careclinical carecommunity buildingcommunity engagementdesigndisparity reductionevidence baseimprovedinnovationinterestoutcome disparitiesresearch studyresponsesimulationtechnology developmenttool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
This application is being submitted in response to the Notice of Special Interest (NOSI) identified as
NOT-CA-23-044.
The Stanford Cancer Institute’s (SCI) [2P30CA124435-14] mission is to leverage the broad and unique
strengths of Stanford University in basic science, bioengineering, population science, biostatistics, technology
development, clinical research, clinical care, and translation to (1) improve the diagnosis, treatment, and
outcomes of cancer patients; (2) understand cancer etiologies among diverse populations; and (3) decrease
cancer incidence in the SCI catchment area and beyond. SCI is committed to understanding and addressing
the cancer burden and reducing cancer disparities in our community. This proposal is in direct response to a
request from the SCI Community Advisory Board to foster research on strategies to reduce disparities in
access to evidence-based cancer care services in the catchment area at the patient and community level.
Cancer research discoveries over the last 30 years have stimulation critical innovations in cancer prevention
and care delivery, greatly improving cancer survival. However, communities with the greatest cancer burden
are often last to benefit from these innovations. Community benefit policies, including medical financial
assistance and community-building initiatives, aim to incentivize hospital systems to address the needs of
underserved patients and communities. Yet, the effectiveness of these policies in addressing persistent
disparities in cancer care access and burden are largely unknown.
Building on our prior research on community benefits, this proposal aims to engage community and health
system partners in the development of more equity-focused community benefit policies to improve cancer
outcomes and reduce disparities. Specifically, we seek to understand the complex and interacting factors that
drive community benefit spending in order to inform equity-focused allocation decisions in the 10-county SCI
catchment area. Activities proposed in this research supplement will establish a foundation for future research
studies to develop and validate a simulation-based tool to inform the allocation of community benefits in ways
that better address critical financial assistance needs for cancer patients and foster a more equitable allocation
of community benefit resources.
期刊论文(553)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1038/s41598-022-11800-w
发表时间:
2022-05-16
期刊:
Scientific reports
影响因子:
4.6
作者:
[]
通讯作者:
DOI:
10.1016/j.canlet.2013.12.020
发表时间:
2014-04-28
期刊:
CANCER LETTERS
影响因子:
9.7
作者:
[Hu, Xiang, Liu, Yang, Qin, Chunxia, Pan, Zhenyu, Luo, Jun, Yu, Aixi, Cheng, Zhen]
通讯作者:
Cheng, Zhen
DOI:
10.1038/s41598-018-27946-5
发表时间:
2018-07-03
期刊:
Scientific reports
影响因子:
4.6
作者:
[Banerjee I, Gensheimer MF, Wood DJ, Henry S, Aggarwal S, Chang DT, Rubin DL]
通讯作者:
Rubin DL
DOI:
10.1177/1740774512437252
发表时间:
2012-04
期刊:
Clinical trials (London, England)
影响因子:
--
作者:
[Lai TL, Lavori PW, Shih MC, Sikic BI]
通讯作者:
Sikic BI
DOI:
10.1016/j.phrs.2021.105780
发表时间:
2021-09
期刊:
Pharmacological research
影响因子:
9.3
作者:
[Wu W, Klockow JL, Zhang M, Lafortune F, Chang E, Jin L, Wu Y, Daldrup-Link HE]
通讯作者:
Daldrup-Link HE
共 355 条
Project 2: Immune signals promoting pancreas cancer stemness and progression
-
批准号:10704088
-
项目类别:
-
资助金额:$41.46万
-
财政年份:2021
-
负责人:STEVEN E ARTANDI
-
依托单位:
Project 2: Immune signals promoting pancreas cancer stemness and progression
-
批准号:10456770
-
项目类别:
-
资助金额:$41.46万
-
财政年份:2021
-
负责人:STEVEN E ARTANDI
-
依托单位:
Determining the role of TCAB1 in shaping telomerase function
-
批准号:10228562
-
项目类别:
-
资助金额:$47.01万
-
财政年份:2017
-
负责人:STEVEN E ARTANDI
-
依托单位:
Determining the role of TCAB1 in shaping telomerase function
-
批准号:9927965
-
项目类别:
-
资助金额:$46.33万
-
财政年份:2017
-
负责人:STEVEN E ARTANDI
-
依托单位:
Determining the role of TCAB1 in shaping telomerase function
-
批准号:9366667
-
项目类别:
-
资助金额:$44.83万
-
财政年份:2017
-
负责人:STEVEN E ARTANDI
-
依托单位:
REVERSING CELLULAR IMMORTALITY IN CANCER
-
批准号:9188490
-
项目类别:
-
资助金额:$1.07万
-
财政年份:2016
-
负责人:STEVEN E ARTANDI
-
依托单位:
Reversing Cellular immortality in cancer
-
批准号:9750644
-
项目类别:
-
资助金额:$93.37万
-
财政年份:2015
-
负责人:STEVEN E ARTANDI
-
依托单位:
Reversing Cellular immortality in cancer
-
批准号:9139884
-
项目类别:
-
资助金额:$97.26万
-
财政年份:2015
-
负责人:STEVEN E ARTANDI
-
依托单位:
Reversing Cellular immortality in cancer
-
批准号:8956267
-
项目类别:
-
资助金额:$63.25万
-
财政年份:2015
-
负责人:STEVEN E ARTANDI
-
依托单位:
Reversing Cellular immortality in cancer
-
批准号:9266050
-
项目类别:
-
资助金额:$1.87万
-
财政年份:2015
-
负责人:STEVEN E ARTANDI
-
依托单位:
Reversing Cellular immortality in cancer
-
批准号:10216186
-
项目类别:
-
资助金额:$97.21万
-
财政年份:2015
-
负责人:STEVEN E ARTANDI
-
依托单位:
Reversing Cellular immortality in cancer
-
批准号:9341180
-
项目类别:
-
资助金额:$96.29万
-
财政年份:2015
-
负责人:STEVEN E ARTANDI
-
依托单位:
Reversing Cellular immortality in cancer
-
批准号:9975795
-
项目类别:
-
资助金额:$96.29万
-
财政年份:2015
-
负责人:STEVEN E ARTANDI
-
依托单位:
Program in Translational and Experimental Hematology
-
批准号:9090171
-
项目类别:
-
资助金额:$28.79万
-
财政年份:2014
-
负责人:STEVEN E ARTANDI
-
依托单位:
Program in Translational and Experimental Hematology
-
批准号:8843948
-
项目类别:
-
资助金额:$27.88万
-
财政年份:2014
-
负责人:STEVEN E ARTANDI
-
依托单位:
Program in Translational and Experimental Hematology
-
批准号:9294100
-
项目类别:
-
资助金额:$20.41万
-
财政年份:2014
-
负责人:STEVEN E ARTANDI
-
依托单位:
Defining the telomerase holoenzyme in progenitor cells with aging
-
批准号:8411145
-
项目类别:
-
资助金额:$30.5万
-
财政年份:2010
-
负责人:STEVEN E ARTANDI
-
依托单位:
Defining the telomerase holoenzyme in progenitor cells with aging
-
批准号:8605142
-
项目类别:
-
资助金额:$32.3万
-
财政年份:2010
-
负责人:STEVEN E ARTANDI
-
依托单位:
Defining the telomerase holoenzyme in progenitor cells with aging
-
批准号:7785005
-
项目类别:
-
资助金额:$33.49万
-
财政年份:2010
-
负责人:STEVEN E ARTANDI
-
依托单位:
Defining the telomerase holoenzyme in progenitor cells with aging
-
批准号:8013591
-
项目类别:
-
资助金额:$32.22万
-
财政年份:2010
-
负责人:STEVEN E ARTANDI
-
依托单位:
海外基金